SHARON MARAMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AUSTELL, GA NPI 1275015372
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GA Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$109.17
- Category: General Payments
- Program years: PY2021
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $109.17 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $109.17 | 8 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $81.66 | 5 |
| Genentech USA, Inc. | $14.51 | 2 |
| Merck Sharp & Dohme Corporation | $13.00 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2021 | $109.17 | 8 |
Records — PY2021 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 820541919 | Takeda Pharmaceuticals U.S.A., Inc. | $16.05 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 820541923 | Takeda Pharmaceuticals U.S.A., Inc. | $17.55 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 820541927 | Takeda Pharmaceuticals U.S.A., Inc. | $20.56 | 03/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 820541931 | Takeda Pharmaceuticals U.S.A., Inc. | $12.50 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 820541935 | Takeda Pharmaceuticals U.S.A., Inc. | $15.00 | 07/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 836081227 | Genentech USA, Inc. | $3.68 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 836081229 | Genentech USA, Inc. | $10.83 | 11/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 848447557 | Merck Sharp & Dohme Corporation | $13.00 | 02/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.